Voyager Therapeutics (VYGR) Tops Q4 EPS by 5c

Voyager Therapeutics (NASDAQ: VYGR) reported Q4 EPS of ($0.46), $0.05 better than the analyst estimate of ($0.51). Revenue for the quarter came in at $15.34 million versus the consensus estimate of $9.19 million.

For earnings history and earnings-related data on Voyager Therapeutics (VYGR) click here.

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Genco Shipping & Trading Limited (GNK) 8400 contracts of August 30 calls trade, share price up 5.5%